Chemours (NYSE:CC) Receives Equal Weight Rating from Morgan Stanley
Chemours (NYSE:CC – Get Free Report)‘s stock had its “equal weight” rating reaffirmed by research analysts at Morgan Stanley in a research report issued to clients and investors on Tuesday, Benzinga reports. They currently have a $33.00 target price on the specialty chemicals company’s stock. Morgan Stanley’s price objective points to a potential downside of […]